Published in

Springer, Clinical and Experimental Metastasis, 6(33), p. 609-627, 2016

DOI: 10.1007/s10585-016-9801-2

Links

Tools

Export citation

Search in Google Scholar

MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO